^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    ColoSense™

    Company:
    Geneoscopy
    Type:
    FDA Approved
    Related tests:

    Details

    Evidence
    News
    ColoSense is the first noninvasive colorectal cancer screening test to provide a dynamic view of disease activity by using RNA biomarkers. ColoSense harnesses the power of RNA biomarkers to aid in the detection of colorectal cancer and advanced adenomas.
    Cancer:
    Colorectal Cancer
    Method:
    RNA-based molecular screening test
    Approvals
    Date
    Cancer
    Gene
    Drug
    By
    05/06/24
    CRC
    -
    FDA